162 related articles for article (PubMed ID: 24129929)
1. Increase in ezrin expression from benign to malignant breast tumours.
Gschwantler-Kaulich D; Natter C; Steurer S; Walter I; Thomas A; Salama M; Singer CF
Cell Oncol (Dordr); 2013 Dec; 36(6):485-91. PubMed ID: 24129929
[TBL] [Abstract][Full Text] [Related]
2. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
[TBL] [Abstract][Full Text] [Related]
3. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas.
Sarrió D; Rodríguez-Pinilla SM; Dotor A; Calero F; Hardisson D; Palacios J
Breast Cancer Res Treat; 2006 Jul; 98(1):71-9. PubMed ID: 16538541
[TBL] [Abstract][Full Text] [Related]
4. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
[TBL] [Abstract][Full Text] [Related]
5. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.
Yang L; Guo T; Jiang S; Yang Z
Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411
[TBL] [Abstract][Full Text] [Related]
6. Atypical ezrin localization as a marker of locally advanced breast cancer.
Arslan AA; Silvera D; Arju R; Giashuddin S; Belitskaya-Levy I; Formenti SC; Schneider RJ
Breast Cancer Res Treat; 2012 Aug; 134(3):981-8. PubMed ID: 22415480
[TBL] [Abstract][Full Text] [Related]
7. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
[TBL] [Abstract][Full Text] [Related]
8. Ezrin is Significantly Overexpressed in Luminal A, Luminal B, and HER2 Subtype Breast Cancer.
Jais MH; Md Zin RR; Muhd Hanapi NA; Md Ali SA
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):44-48. PubMed ID: 26469327
[TBL] [Abstract][Full Text] [Related]
9. Ezrin is associated with gastric cancer progression and prognosis.
Li L; Wang YY; Zhao ZS; Ma J
Pathol Oncol Res; 2011 Dec; 17(4):909-15. PubMed ID: 21717114
[TBL] [Abstract][Full Text] [Related]
10. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
[TBL] [Abstract][Full Text] [Related]
11. Low-dose epirubicin inhibits ezrin-mediated metastatic behavior of breast cancer cells.
Ma L; Liu YP; Geng CZ; Xing LX; Zhang XH
Tumori; 2011; 97(3):400-5. PubMed ID: 21789023
[TBL] [Abstract][Full Text] [Related]
12. Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases.
Bartova M; Hlavaty J; Tan Y; Singer C; Pohlodek K; Luha J; Walter I
Clin Exp Metastasis; 2017 Jun; 34(5):333-344. PubMed ID: 28624994
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of Ezrin and CD44 co‑expression in breast cancer.
Ma L; Jiang T
Oncol Rep; 2013 Oct; 30(4):1899-905. PubMed ID: 23900701
[TBL] [Abstract][Full Text] [Related]
14. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
[TBL] [Abstract][Full Text] [Related]
15. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.
Jin J; Jin T; Quan M; Piao Y; Lin Z
Diagn Pathol; 2012 Oct; 7():135. PubMed ID: 23039327
[TBL] [Abstract][Full Text] [Related]
16. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
17. Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells.
Li Q; Gao H; Xu H; Wang X; Pan Y; Hao F; Qiu X; Stoecker M; Wang E; Wang E
Tumour Biol; 2012 Oct; 33(5):1493-504. PubMed ID: 22528947
[TBL] [Abstract][Full Text] [Related]
18. Expression of ezrin correlates with poor prognosis of nasopharyngeal carcinoma.
Wang L; Lin GN; Jiang XL; Lu Y
Tumour Biol; 2011 Aug; 32(4):707-12. PubMed ID: 21625943
[TBL] [Abstract][Full Text] [Related]
19. Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.
Schimmelpenning H; Eriksson ET; Falkmer UG; Azavedo E; Svane G; Auer GU
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):433-40. PubMed ID: 1350695
[TBL] [Abstract][Full Text] [Related]
20. High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy.
Wang HJ; Zhu JS; Zhang Q; Sun Q; Guo H
World J Gastroenterol; 2009 Apr; 15(16):2016-9. PubMed ID: 19399936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
